The growing prevalence of dental disorders, rising geriatric population, and the growing dental tourism in emerging countries are the major factors driving the growth of this market. On the other hand, the presence of stringent regulatory and clinical processes is one of the major factors restraining market growth.

Dental implant and prosthetic manufacturers, dental laboratories, dental hospitals and clinics, and dental academies and research institutes. In 2018, the dental implant and prosthetic manufacturers segment accounted for the largest of the dental biomaterials market. The large share of this segment can be attributed to the increasing penetration of dental implants and prosthetics, growing adoption of CAD/CAM systems in dental clinics and laboratories, increasing number of dental practices, and the rising awareness on oral diseases.

The global dental biomaterials market is projected to reach USD 9.6 billion by 2023 from USD 6.7 billion in 2018, at a CAGR of 7.4%.

Recent Developments

• In 2018, The Straumann Group acquired a 30% stake in its biomaterials partner, Botiss medical AG, for an undisclosed sum. This acquisition enables Straumann to expand its dental biomaterials portfolio.
• In 2018, Henry Schein, Inc. acquired Intra-Lock (Spain), a provider of dental restoration solutions. This will enhance its position in the premium implant segment
• In 2018, Carpenter Technology Corporation announced the expansion of its Emerging Technology Center in the Alabama Campus (US).
• In 2017, Geistlich Pharma opened its tenth subsidiary in India. This marked Geistlich’s entry into a potentially interesting market for regenerative dentistry.

To speak to our analyst for a discussion on the above findings, click Speak to Analyst